Acute-phase response in patients given rhIL-3 after chemotherapy.
J A
JA
Gietema
P E
PE
Postmus
B
B
Biesma
P C
PC
Limburg
E
E
Vellenga
E G
EG
de Vries
D000210:Acute-Phase Reaction / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D007377:Interleukin-3 / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects
D000970:Antineoplastic Agents; D007377:Interleukin-3; D011994:Recombinant Proteins